Biomed Central Ltd

SHERPA: Unknown

People

  1. O'Reilly
    O'Reilly
  2. Khalil
    Khalil
  3. Park
    Park
  4. Abou-Alfa
    Abou-Alfa
  5. Segal
    Segal
  6. Ku
    Ku
  7. Diaz
    Diaz
  8. Janjigian
    Janjigian
  9. Harding
    Harding
  10. Maron
    Maron

Groups

  1. Department of Medicine (68)
  2. Gastrointestinal Oncology Service (68)
  3. Solid Tumor Oncology Division (68)
  4. Center for Pancreatic Cancer Research (33)
  5. GSK Faculty (13)
  6. MSK Grad Students (11)
  7. Hematologic Malignancies, Division of (10)
  8. CTCR Scholars (9)
  9. Hematology-Oncology Fellows (9)
  10. Master of Science in Clinical and Translational Cancer Research (9)
Search Within
  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (36)
  2. Meeting Abstract (26)
  3. Editorial (2)
  4. Guidelines (2)
  5. Correspondence (1)
  6. Review (1)
Groups
  1. Department of Medicine (68)
  2. Gastrointestinal Oncology Service (68)
  3. Solid Tumor Oncology Division (68)
  4. Center for Pancreatic Cancer Research (33)
  5. GSK Faculty (13)
  6. MSK Grad Students (11)

More Groups

People
  1. Eileen O'Reilly (13)
  2. Danny Khalil (9)
  3. Wungki Park (9)
  4. Ghassan Abou-Alfa (8)
  5. Neil Segal (6)
  6. Geoffrey Ku (5)

More People

Years
  1. 2025 (2)
  2. 2024 (6)
  3. 2023 (5)
  4. 2022 (10)
  5. 2021 (6)
  6. 2020 (8)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (48)
  2. BMC Cancer (9)
  3. Genome Biology (5)
  4. World Journal of Surgical Oncology (3)
  5. BMC Genomics (1)
  6. BMC Palliative Care (1)

More Publications

Results (68)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immune checkpoint blockade and transarterial chemoembolization in liver-limited hepatocellular carcinoma: New questions at the dawn of a new era
    Editorial

    Dhyani, A.; Harding, J. J.
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • Intraperitoneal CAR T-cell therapy for peritoneal carcinomatosis from gastroesophageal cancer: Preclinical investigations to a phase I clinical trial (NCT06623396)
    Journal Article

    Restle, D.; Amador-Molina, A.; Misawa, K.; Banerjee, S.; Ku, G.; Adusumilli, P. S.
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • First-in-human clinical outcomes with NG-350A, an anti-CD40 expressing tumor-selective vector designed to remodel immunosuppressive tumor microenvironments
    Journal Article

    Naing, A.; Khalil, D.; Rosen, O.; Camidge, D. R.; Lillie, T.; Ji, R. R.; Stacey, A.; Thomas, M.; Rosen, L.
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: A randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer
    Journal Article

    Alvarez, J. A.; Shi, Q.; Dasari, A.; Garcia-Aguilar, J.; Sanoff, H.; George, T. J.; Hong, T.; Yothers, G.; Philip, P.; Nelson, G.; more...
    BMC Cancer (2024)

    Fulltext@MSK | Save
  • Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors
    Journal Article

    Khushalani, N. I.; Ott, P. A.; Ferris, R. L.; Cascone, T.; Schadendorf, D.; Le, D. T.; Sharma, M. R.; Barlesi, F.; Sharfman, W.; Luke, J. J.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032)
    Journal Article

    Callahan, M.; Amin, A.; Kaye, F. J.; Morse, M. A.; Taylor, M. H.; Peltola, K. J.; Sharma, P.; O'Reilly, E. M.; Meadows Shropshire, S.; O'Brien, S.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: Evaluating Radiation, Ablation, and Surgery (ERASur)
    Journal Article

    Hitchcock, K. E.; Miller, E. D.; Shi, Q.; Dixon, J. G.; Gholami, S.; White, S. B.; Wu, C.; Goulet, C. C.; George, M.; Jee, K. W.; more...
    BMC Cancer (2024)

    Fulltext@MSK | Save
  • Response to Yu and Fuhler et al
    Correspondence

    Magahis, P. T.; Maron, S. B.; Faleck, D.; Laszkowska, M.
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors
    Journal Article

    Magahis, P. T.; Maron, S. B.; Cowzer, D.; King, S.; Schattner, M.; Janjigian, Y.; Faleck, D.; Laszkowska, M.
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden
    Journal Article

    Florou, V.; Floudas, C. S.; Maoz, A.; Naqash, A. R.; Norton, C.; Tan, A. C.; Sokol, E. S.; Frampton, G.; Soares, H. P.; Puri, S.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save